Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW766944 in Asthma with Sputum Eosinophilia
NCT01160224Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GW766994 in asthma, sponsored by GSK. Started Sep 2010; status: completed.
02
Drugs
GW766994
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01160224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160224.